ANNUAL FINANCIAL REPORT OF THE AB SCIENCE GROUP
FOR THE YEAR ENDING 31 DECEMBER 2023
July 2024 Corporate Presentation
Last financial results
HALF-YEAR FINANCIAL REPORT OF THE AB SCIENCE GROUP
AT 30 JUNE 2023
AB Science
Masitinib and AB8939 – Two compounds with breakthrough mechanism of action
- Home
- Company
- Science
- Pipeline
- News and Media
- Investors
- Masivet®
- Careers
- Contact